Table 2 Ultrasound and laboratory examination results of patients

Tumor-adjacent tissue hardnss

13.46 ± 5.72

11.16 ± 5.63

15.32 ± 5.14

0.001

Tumor hardnss

11.66 ± 8.16

12.95 ± 7.33

10.62 ± 8.72

0.225

SR

1.85 ± 1.27

1.48 ± 0.89

2.15 ± 1.45

0.023

AFP

16.92 (1–1210)

363.10 (2–1210.0)

5.93 (1–1210)

0.006

PIVKA-II

252 (0–64, 199)

958 (0–64, 199)

99 (0–16, 602)

0.026

WBC

5.17 ± 1.95

5.04 ± 1.93

5.28 ± 1.99

0.600

PLT

167.62 ± 66.93

176.15 ± 62.10

160.76 ± 70.58

0.329

RDW

12.55 (11.3–19.5)

12.4 (11.5–19.5)

12.6 (11.3–17.7)

0.304

PT

11.5 (10.0–15.3)

11.5 (10.2–13.1)

11.5 (10.0–15.3)

0.446

ALB

41.69 ± 3.61

41.0 ± 3.59

42.19 ± 3.58

0.342

ALT

26 (11–91)

26 (12–74)

27 (11–91)

0.433

AST

26 (11–112)

27 (11–101)

26 (15–112)

0.325

GGT

39.5 (11–210)

41 (11–210)

39 (11–161)

0.253

TB

12.9 (5.1–40.5)

14.3 (6.5–40.5)

12.3 (5.1–30.6)

0.064

ALP

81 (38–347)

84 (38–347)

80 (38–187)

0.691

Glu

5.16 (3.33–16.26)

5.13 (3.57–14.01)

5.19 (3.33–16.26)

0.539